Clover Corporation Limited (CLV) - 1H25 Results – Turnaround Underway
Expansion into New Products: In its 1H25 update, management highlighted the growth of its new product segment, which now accounts for 50% of CLV’s...
373 Views
Clover Corporation Limited (CLV) - FY24 Results – Corner Turned in 2H24?
CLV is experiencing cyclically low demand for its products caused by a backlog of infant formula in China from a change in infant formula standards...
272 Views
Clover Corporation Limited (CLV) - 1H24 Result – Infant Formula Continues to Be Tough
CLV is currently experiencing cyclically low demand for its products due to a backlog of infant formula in China and lower birth numbers in many...
254 Views
Clover Corporation Limited (CLV) - Regulatory Catalysts To Drive Growth
CLV is the world leader in the manufacture of encapsulated Docosahexaenoic Acid (DHA) predominantly sold to infant formula manufacturers.
480 Views
Aussie Healthcare Daily: 4 Dec 2017
The Aussie Healthcare Daily is a summary of major news and announcements from ASX-listed healthcare companies as well as developments and trends in...
422 Views